Moderna Developing mRNA Vaccines for Multiple Diseases Reportedly Linked to the COVID Shot
Last week, Moderna announced progress on several mRNA-based vaccines for diseases, including many reportedly linked to the COVID-19 shot.
The Defender reported that three of these shots in question, the Epstein-Barr virus (EBV), Varicella-zoster virus (VZV, chickenpox and shingles), and Norovirus have advanced to “pivotal late-stage development.”
Moderna also revealed in their announcement that the U.S. Food and Drug Administration (FDA) will likely approve its respiratory syncytial virus (RSV) vaccine mRNA-1345 for older adults. The Defender notes this is part of an expected $52 billion market for Moderna’s infectious disease vaccines.
Vaccines for cancer and autoimmune diseases are also under development by Moderna.
All of this could prove problematic. The Defender notes that multiple reports have linked COVID-19 vaccines to shingles and EBV.
From the Defender:
A 2021 paper reported 54 cases of herpes zoster (shingles) emerging an average of 7 days after COVID-19 vaccination. A 2022 paper reported 10 cases of herpes zoster reactivation within one to three weeks after COVID-19 vaccination.
French scientist Hélène Banoun, Ph.D., in “La Science face au Pouvoir: Ce que révèle la crise Covid-19 sur la biopolitique du XXIe siècle” (“Science versus Power: What the Covid-19 crisis reveals about 21st-century biopolitics”), wrote that the disorganization of the innate immune system and its receptors contribute to the reactivation of latent viruses — including herpes, shingles, human papillomavirus (HPV) and RSV.
https://www.thegatewaypundit.com/2024/04/here-we-go-moderna-developing-mrna-vaccines-multiple/